國立高雄大學圖資館 |

Disruptive psychopharmacology

Record Type:	Electronic resources : Monograph/item
Title/Author:	Disruptive psychopharmacologyedited by Frederick S. Barrett, Katrin H. Preller.
other author:	Preller, Katrin H.
Published:	Cham :Springer International Publishing :2022.
Description:	viii, 332 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	Psychopharmacology.
Online resource:	https://doi.org/10.1007/978-3-031-12184-5
ISBN:	9783031121845$q(electronic bk.)

Disruptive psychopharmacology
Disruptive psychopharmacology[electronic resource] /edited by Frederick S. Barrett, Katrin H. Preller. - Cham :Springer International Publishing :2022. - viii, 332 p. :ill., digital ;24 cm. - Current topics in behavioral neurosciences,v. 561866-3389 ;. - Current topics in behavioral neurosciences ;9..

Dosing psychedelics and MDMA -- Psychedelic Group Therapy -- Set and Setting: Aesthetic experiences and their contribution to psychedelic therapies -- Psychedelic-Assisted Therapy for Social Adaptability in Autistic Adults -- Foundations for Training Psychedelic Therapists -- Ayahuasca for the Treatment of Depression -- Psilocybin for the Treatment of Depression -- Ketamine for the Treatment of Depression -- The Potential of Psychedelics for End of Life and Palliative Care -- Psychedelic-Assisted Therapy for Addiction and Potential Mechanisms of Action -- Psilocybin for Tobacco Use Disorder -- Psychedelic Drugs as Anti-Inflammatory Agents -- Psilocybin for the Treatment of Obsessive-Compulsive Disorder -- Psilocybin for the Treatment of Headache and Pain Disorders -- Psilocybin for the Treatment of Neurodegenerative Disorders -- Psilocybin for Trauma-Related Disorders.

Psychedelic therapies are gaining traction as potential treatments for a wide range of indications, but the structure and delivery of psychedelic therapies are a sharp departure from more traditional models of psychotherapy and pharmacotherapy for psychiatric and other medical disorders. This may be critical to their success. The current volume provides a comprehensive review of the state of the science of psychedelic therapies, including discussion of models and approaches to psychedelic therapies as well as the current status of safety and efficacy data for mood, substance use, trauma, obsessive-compulsive, neurodevelopmental, neurodegenerative disorders, neurological, and inflammatory disorders.

ISBN: 9783031121845$q(electronic bk.)

Standard No.: 10.1007/978-3-031-12184-5doiSubjects--Topical Terms:

252258
Psychopharmacology.

LC Class. No.: RM315 / .D57 2022

Dewey Class. No.: 615.78

Disruptive psychopharmacology
LDR:02628nmm a2200325 a 4500 001 628783
003 DE-He213
005 20220825211925.0
007 cr nn 008maaau
008 230224s2022 sz s 0 eng d
020 $a 9783031121845$q(electronic bk.)
020 $a 9783031121838$q(paper)
024 7 $a 10.1007/978-3-031-12184-5 $2 doi
035 $a 978-3-031-12184-5
040 $a GP $c GP
041 0 $a eng
050 4 $a RM315 $b .D57 2022
072 7 $a PSAN $2 bicssc
072 7 $a MED057000 $2 bisacsh
072 7 $a PSAN $2 thema
082 0 4 $a 615.78 $2 23
090 $a RM315 $b .D613 2022
245 0 0 $a Disruptive psychopharmacology $h [electronic resource] / $c edited by Frederick S. Barrett, Katrin H. Preller.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a viii, 332 p. : $b ill., digital ; $c 24 cm.
490 1 $a Current topics in behavioral neurosciences, $x 1866-3389 ; $v v. 56
505 0 $a Dosing psychedelics and MDMA -- Psychedelic Group Therapy -- Set and Setting: Aesthetic experiences and their contribution to psychedelic therapies -- Psychedelic-Assisted Therapy for Social Adaptability in Autistic Adults -- Foundations for Training Psychedelic Therapists -- Ayahuasca for the Treatment of Depression -- Psilocybin for the Treatment of Depression -- Ketamine for the Treatment of Depression -- The Potential of Psychedelics for End of Life and Palliative Care -- Psychedelic-Assisted Therapy for Addiction and Potential Mechanisms of Action -- Psilocybin for Tobacco Use Disorder -- Psychedelic Drugs as Anti-Inflammatory Agents -- Psilocybin for the Treatment of Obsessive-Compulsive Disorder -- Psilocybin for the Treatment of Headache and Pain Disorders -- Psilocybin for the Treatment of Neurodegenerative Disorders -- Psilocybin for Trauma-Related Disorders.
520 $a Psychedelic therapies are gaining traction as potential treatments for a wide range of indications, but the structure and delivery of psychedelic therapies are a sharp departure from more traditional models of psychotherapy and pharmacotherapy for psychiatric and other medical disorders. This may be critical to their success. The current volume provides a comprehensive review of the state of the science of psychedelic therapies, including discussion of models and approaches to psychedelic therapies as well as the current status of safety and efficacy data for mood, substance use, trauma, obsessive-compulsive, neurodevelopmental, neurodegenerative disorders, neurological, and inflammatory disorders.
650 0 $a Psychopharmacology. $3 252258
650 1 4 $a Neuropharmacology. $3 275141
650 2 4 $a Psychiatry. $3 201470
650 2 4 $a Neurology. $3 211583
700 1 $a Preller, Katrin H. $3 933216
700 1 $a Barrett, Frederick S. $3 933215
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
830 0 $a Current topics in behavioral neurosciences ; $v 9. $3 559431
856 4 0 $u https://doi.org/10.1007/978-3-031-12184-5
950 $a Biomedical and Life Sciences (SpringerNature-11642)